Meningiomas from the Merlin-intact molecular group with favorable clinical outcomes encode recurrent short somatic variants targeting TRAF7, KLF4, PI3K, POLR2A, or the Hedgehog pathway [2, 4, 18, 21, 22, 33, 34]. The gene discussed is NF2; the disease is meningioma.